Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm

Schiavina, 2013, The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?, Curr Radiopharm, 6, 92, 10.2174/1874471011306020005 Patel, 2013, Radiation dose reduction in pediatric CT-guided musculoskeletal procedures, Pediatr Radiol, 43, 1303, 10.1007/s00247-013-2691-4 Tomozawa, 2011, Clinical value of CT guided needle biopsy for retroperitoneal lesions, Korean J Radiol, 12, 351, 10.3348/kjr.2011.12.3.351 Guimaraes, 2003, Computed tomography-guided needle biopsies in pediatric oncology, J Pediatr Surg, 38, 1066, 10.1016/S0022-3468(03)00194-5 Cornud, 2018, MR imaging-guided prostate interventional imaging: ready for a clinical use?, Diagn Interv Imaging, 99, 743, 10.1016/j.diii.2018.08.002 Iguchi, 2018, CT fluoroscopy-guided core needle biopsy of anterior mediastinal masses, Diagn Interv Imaging, 99, 91, 10.1016/j.diii.2017.10.007 El-Haddad, 2016, PET-based percutaneous needle biopsy, PET Clin, 11, 333, 10.1016/j.cpet.2016.02.009 Klaeser, 2009, PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences, Eur Radiol, 19, 1780, 10.1007/s00330-009-1338-1 Cornelis, 2014, Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities, Eur J Nucl Med Mol Imaging, 41, 2265, 10.1007/s00259-014-2852-1 Haidar, 2017, The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers, Nucl Med Commun, 38, 170, 10.1097/MNM.0000000000000623 Hofman, 2015, Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation, Radiographics, 35, 500, 10.1148/rg.352140164 Maurer, 2016, Current use of PSMA-PET in prostate cancer management, Nat Rev Urol, 13, 226, 10.1038/nrurol.2016.26 Backhaus, 2018, Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives, Eur J Nucl Med Mol Imaging, 45, 860, 10.1007/s00259-017-3922-y Malik, 2018, 68Ga-labeled PSMA uptake in nonprostatic malignancies: has the time come to remove “PS” from PSMA?, Clin Nucl Med, 43, 529, 10.1097/RLU.0000000000002103 Vag, 2016, First experience with chemokine receptor CXCR4–targeted PET imaging of patients with solid cancers, J Nucl Med, 57, 741, 10.2967/jnumed.115.161034 Weiss, 2013, Molecular imaging of chemokine receptor CXCR4, Theranostics, 3, 76, 10.7150/thno.4835 Patel, 2012, Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions, J Vasc Interv Radiol, 23, 727, 10.1016/j.jvir.2012.02.012 Kumar, 2019, Diagnostic performance of real-time robotic arm-assisted (18)F-FDG PET/CT-guided percutaneous biopsy in metabolically active abdominal and pelvic lesions, Eur J Nucl Med Mol Imaging, 46, 838, 10.1007/s00259-018-4133-x Kumar, 2019, (18)F-FDG PET/CT-guided real-time automated robotic arm-assisted needle navigation for percutaneous biopsy of hypermetabolic bone lesions: diagnostic performance and clinical impact, AJR Am J Roentgenol, 212, W10, 10.2214/AJR.18.19698 Radhakrishnan, 2017, Real-time intraprocedural (18)F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health care centre, Br J Radiol, 90, 20170258, 10.1259/bjr.20170258 Lakhanpal, 2018, Radiation exposure to the personnel performing robotic arm-assisted positron emission tomography/computed tomography-guided biopsies, Indian J Nucl Med, 33, 209 Krishnaraju, 2018, Incidental detection of Type B2 thymoma on 68Ga-labeled prostate specific membrane antigen PET/CT imaging, Clin Nucl Med, 43, 356, 10.1097/RLU.0000000000002000 Malik, 2018, Incidental detection of tracer avidity in liposarcoma on 68Ga-labeled prostate-specific membrane antigen PET/CT, Clin Nucl Med, 43, e334, 10.1097/RLU.0000000000002189 Kumar, 2019, 68Ga CXCR-4 PET/CT imaging in an atypical case of extramedullary plasmacytoma mimicking as renal cell carcinoma, Clin Nucl Med, 44, e461, 10.1097/RLU.0000000000002574 Breeman, 2007, The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?, Eur J Nucl Med Mol Imaging, 34, 978, 10.1007/s00259-007-0387-4 Sudbrock, 2014, Characterization of SnO2-based (68)Ge/(68)Ga generators and (68)GaDOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy, EJNMMI Res, 4, 36, 10.1186/s13550-014-0036-4 Velikyan, 2013, Prospective of Ga-radiopharmaceutical development, Theranostics, 4, 47, 10.7150/thno.7447 Shetty, 2010, (68)Ga-labeled radiopharmaceuticals for positron emission tomography, Nucl Med Mol Imaging, 44, 233, 10.1007/s13139-010-0056-6 Hofman, 2012, High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours, J Med Imaging Radiat Oncol, 56, 40, 10.1111/j.1754-9485.2011.02327.x Barrio, 2017, The impact of somatostatin receptor-directed PET/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis, J Nucl Med, 58, 756, 10.2967/jnumed.116.185587 Hoffmann, 2017, Diagnostic performance of (68)Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with (18)FEC PET/CT, Oncotarget, 8, 111073, 10.18632/oncotarget.22441 Omura, 2011, Revisiting CT-guided percutaneous core needle biopsy of musculoskeletal lesions: contributors to biopsy success, AJR Am J Roentgenol, 197, 457, 10.2214/AJR.10.6145 Kobayashi, 2012, Image-guided biopsy: what the interventional radiologist needs to know about PET/CT, Radiographics, 32, 1483, 10.1148/rg.325115159 Cerci, 2017, Comparison of CT and PET/CT for biopsy guidance in oncological patients, Eur J Nucl Med Mol Imaging, 44, 1269, 10.1007/s00259-017-3658-8 Guo, 2017, PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique, Eur J Nucl Med Mol Imaging, 44, 25, 10.1007/s00259-016-3455-9 Aparici, 2014, Initial experience of utilizing real-time intra-procedural PET/CT biopsy, J Clin Imaging Sci, 4, 54, 10.4103/2156-7514.141941 Cerci, 2016, Fluorodeoxyglucose-PET/computed tomography-guided biopsy, PET Clin, 11, 57, 10.1016/j.cpet.2015.08.001 Radhakrishnan, 2018, Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm, Nucl Med Commun, 39, 74, 10.1097/MNM.0000000000000780 Cornelis, 2018, Long-half-life (89)Zr-labeled radiotracers can guide percutaneous biopsy within the PET/CT suite without reinjection of radiotracer, J Nucl Med, 59, 399, 10.2967/jnumed.117.194480 2007, The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103, Ann ICRP, 37, 1